Paper7525859
ATP alters current fluctuations of cystic fibrosis transmembrane conductance regulator: evidence for a three-state activation mechanism.
Venglarik CJ and 3 others. J Gen Physiol, 1994. Cited by 76 papers, by iCite.
Cite this record
ConductScience Library. ATP alters current fluctuations of cystic fibrosis transmembrane conductance regulator: evidence for a three-state activation mechanism. Papers, record 7525859. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7525859
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenosine Triphosphate | Major topic |
| Chloride Channels | Major topic |
| Cystic Fibrosis | Major topic |
| Membrane Proteins | Major topic |
| Animals | |
| Computers | |
| Cystic Fibrosis Transmembrane Conductance Regulator | |
| Ion Channel Gating | |
| L Cells | |
| Mathematics | |
| Mice | |
| Patch-Clamp Techniques |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| DK-38518 | NIDDK NIH HHS | United States | P01DK038518 | PubMed and NIH | NIH RePORTER |
| DK-42017 | NIDDK NIH HHS | United States | P50DK042017 | PubMed and NIH | NIH RePORTER |
| DK-45970 | NIDDK NIH HHS | United States | R01DK045970 | PubMed and NIH | NIH RePORTER |
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40154618 | A cluster of inhibitory residues in the regulatory domain prevents activation of the cystic fibrosis transmembrane conductance regulator. | J Biol Chem | 2025 | https://conductscience.org/library/papers/40154618 | PubMed |
| 38186087 | Two rare variants that affect the same amino acid in CFTR have distinct responses to ivacaftor. | J Physiol | 2024 | https://conductscience.org/library/papers/38186087 | PubMed |
| 34644413 | A small molecule CFTR potentiator restores ATP-dependent channel gating to the cystic fibrosis mutant G551D-CFTR. | Br J Pharmacol | 2022 | https://conductscience.org/library/papers/34644413 | PubMed |
| 32923987 | Pendrin stimulates a chloride absorption pathway to increase CFTR-mediated chloride secretion from Cystic Fibrosis airway epithelia. | FASEB Bioadv | 2020 | https://conductscience.org/library/papers/32923987 | PubMed |
| 32102849 | Protein kinase A phosphorylation potentiates cystic fibrosis transmembrane conductance regulator gating by relieving autoinhibition on the stimulatory C terminus of the regulatory domain. | J Biol Chem | 2020 | https://conductscience.org/library/papers/32102849 | PubMed |
| 30969810 | Differential thermostability and response to cystic fibrosis transmembrane conductance regulator potentiators of human and mouse F508del-CFTR. | Am J Physiol Lung Cell Mol Physiol | 2019 | https://conductscience.org/library/papers/30969810 | PubMed |
| 29318594 | Partial rescue of F508del-cystic fibrosis transmembrane conductance regulator channel gating with modest improvement of protein processing, but not stability, by a dual-acting small molecule. | Br J Pharmacol | 2018 | https://conductscience.org/library/papers/29318594 | PubMed |
| 27779763 | Altering intracellular pH reveals the kinetic basis of intraburst gating in the CFTR Cl- channel. | J Physiol | 2017 | https://conductscience.org/library/papers/27779763 | PubMed |
| 24902474 | CFTR potentiators partially restore channel function to A561E-CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del-CFTR. | Br J Pharmacol | 2014 | https://conductscience.org/library/papers/24902474 | PubMed |
| 24108353 | Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/24108353 | PubMed |
| 21594800 | Application of high-resolution single-channel recording to functional studies of cystic fibrosis mutants. | Methods Mol Biol | 2011 | https://conductscience.org/library/papers/21594800 | PubMed |
| 21576373 | Mutant cycles at CFTR's non-canonical ATP-binding site support little interface separation during gating. | J Gen Physiol | 2011 | https://conductscience.org/library/papers/21576373 | PubMed |
| 21447157 | Interaction of ATP with fibroblast growth factor 2: biochemical characterization and consequence for growth factor stability. | BMC Biochem | 2011 | https://conductscience.org/library/papers/21447157 | PubMed |
| 20876359 | Involvement of F1296 and N1303 of CFTR in induced-fit conformational change in response to ATP binding at NBD2. | J Gen Physiol | 2010 | https://conductscience.org/library/papers/20876359 | PubMed |
| 18957373 | Review. ATP hydrolysis-driven gating in cystic fibrosis transmembrane conductance regulator. | Philos Trans R Soc Lond B Biol Sci | 2009 | https://conductscience.org/library/papers/18957373 | PubMed |
| 18223673 | Prolonged treatment of cells with genistein modulates the expression and function of the cystic fibrosis transmembrane conductance regulator. | Br J Pharmacol | 2008 | https://conductscience.org/library/papers/18223673 | PubMed |
| 17021796 | CFTR (ABCC7) is a hydrolyzable-ligand-gated channel. | Pflugers Arch | 2007 | https://conductscience.org/library/papers/17021796 | PubMed |
| 15767295 | CFTR gating I: Characterization of the ATP-dependent gating of a phosphorylation-independent CFTR channel (DeltaR-CFTR). | J Gen Physiol | 2005 | https://conductscience.org/library/papers/15767295 | PubMed |
| 15623556 | Normal gating of CFTR requires ATP binding to both nucleotide-binding domains and hydrolysis at the second nucleotide-binding domain. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/15623556 | PubMed |
| 15596536 | Functional roles of nonconserved structural segments in CFTR's NH2-terminal nucleotide binding domain. | J Gen Physiol | 2005 | https://conductscience.org/library/papers/15596536 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CFTR | 1080 | PubTator's text mining | https://conductscience.org/library/genes/1080 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7525859
GET https://conductscience.org/api/papers/v1/7525859/cited_by?page=2